Cargando…

Clinicopathological relevance of stem cell marker growth and differentiation factor 3 in esophageal squamous cell carcinoma

Esophageal squamous cell carcinoma (ESCC) is the second leading cause of cancer-related deaths in Iran, often diagnosed in advanced stages with a poor prognosis. Growth and differentiation factor 3 (GDF3) is a member of the transforming growth factor-beta (TGF-β) superfamily. It acts as an inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moghaddam, Sara Tahbazzadeh, Forghanifard, Mohammad Mahdi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Open Exploration 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185436/ https://www.ncbi.nlm.nih.gov/pubmed/37205315 http://dx.doi.org/10.37349/etat.2023.00130

Ejemplares similares

MEIS1 promotes expression of stem cell markers in esophageal squamous cell carcinoma
por: Zargari, Selma, et al.
Publicado: (2020)

Ectopic expression of TWIST1 upregulates the stemness marker OCT4 in the esophageal squamous cell carcinoma cell line KYSE30
por: Izadpanah, Mohammad Hossein, et al.
Publicado: (2017)

EZH2 regulates oncomiR-200c and EMT markers in esophageal squamous cell carcinomas
por: Nourmohammadi, Fatemeh, et al.
Publicado: (2022)

WNT and NOTCH signaling pathways as activators for epidermal growth factor receptor in esophageal squamous cell carcinoma
por: Abbaszadegan, Mohammad Reza, et al.
Publicado: (2018)

MEIS1 knockdown may promote differentiation of esophageal squamous carcinoma cell line KYSE‐30
por: Mahmoudian, Reihaneh Alsadat, et al.
Publicado: (2019)

Contribution of TWIST1-EVX1 Axis in Invasiveness of Esophageal Squamous Cell Carcinoma; a Functional Study
por: Ardalan Khales, Sepideh, et al.
Publicado: (2022)

Mastermind-like 1 (MAML-1) as a new metastatic marker in esophageal squamous cell carcinoma
por: Forghanifard, Mohammad M, et al.
Publicado: (2010)

INPP5A/HLA-G1/IL-10/MMP-21 Axis in Progression of Esophageal Squamous Cell Carcinoma
por: Ardalan Khales, Sima, et al.
Publicado: (2022)

TWIST1 Plays Role in Expression of Stemness State Markers in ESCC
por: Izadpanah, Mohammad Hossein, et al.
Publicado: (2022)

Role of MAML1 in targeted therapy against the esophageal cancer stem cells
por: Moghbeli, Meysam, et al.
Publicado: (2019)

Clinicopathological significances of PLOD2, epithelial–mesenchymal transition markers, and cancer stem cells in patients with esophageal squamous cell carcinoma
por: Gong, Xiaomeng, et al.
Publicado: (2022)

HER2 expression and relevant clinicopathological features in esophageal squamous cell carcinoma in a Chinese population
por: Rong, Lulu, et al.
Publicado: (2020)

Loss of heterozygosity and microsatellite instability as predictive markers among Iranian esophageal cancer patients
por: Forghanifard, Mohammad Mahdi, et al.
Publicado: (2016)

Prevalence and Molecular Characterization of Plasmid-mediated Extended-Spectrum β-Lactamase Genes (bala(TEM), bla(CTX )and blA(SHV)) Among Urinary Escherichia coli Clinical Isolates in Mashhad, Iran
por: Nakhaei Moghaddam, Mahboobeh, et al.
Publicado: (2012)

Clinicopathological Significance of BMP7 Expression in Esophageal Squamous Cell Carcinoma
por: Megumi, Koichi, et al.
Publicado: (2011)

Clinicopathological significance of deoxycytidine kinase expression in esophageal squamous cell carcinoma
por: SHIMADA, YUTAKA, et al.
Publicado: (2013)

Correlation of CD146 expression and clinicopathological characteristics in esophageal squamous cell carcinoma
por: LI, YAN, et al.
Publicado: (2014)

Clinicopathological significance of cystatin A expression in progression of esophageal squamous cell carcinoma
por: Shiba, Daiki, et al.
Publicado: (2018)

The Clinicopathological Correlations of hTERC Amplification with Esophageal Squamous Cell Precursor Lesions
por: Hu, Yanping, et al.
Publicado: (2018)

Amplification and clinicopathological significance of HER-2 in Kazakh esophageal squamous cell carcinoma
por: Muhetaer, Aishanjiang, et al.
Publicado: (2020)

ICAM1 Is a Potential Cancer Stem Cell Marker of Esophageal Squamous Cell Carcinoma
por: Tsai, Sheng-Ta, et al.
Publicado: (2015)

Esophageal squamous papilloma lacks clear clinicopathological associations
por: Jideh, Bilel, et al.
Publicado: (2017)

Necroptosis in head and neck squamous cell carcinoma: characterization of clinicopathological relevance and in vitro cell model
por: Li, Jingyuan, et al.
Publicado: (2020)

Interaction between LINC-ROR and Stemness State in Gastric Cancer Cells with Helicobacter pylori Infection
por: Alsadat Mahmoudian, Reihaneh, et al.
Publicado: (2021)

Clinicopathologic characteristics of high expression of Bmi-1 in esophageal adenocarcinoma and squamous cell carcinoma
por: Choy, Bonnie, et al.
Publicado: (2012)

Clinicopathological and prognostic significance of GPX2 protein expression in esophageal squamous cell carcinoma
por: Lei, Zhijin, et al.
Publicado: (2016)

Expression and Clinicopathological Significance of Mel-18 and Bmi-1 in Esophageal Squamous Cell Carcinoma
por: Ji, Huaijun, et al.
Publicado: (2017)

Surgically Resected Esophageal Squamous Cell Carcinoma: Patient Survival and Clinicopathological Prognostic Factors
por: Jeong, Dong Young, et al.
Publicado: (2020)

Distribution of esophagus flora in esophageal squamous cell carcinoma and its correlation with clinicopathological characteristics
por: Hu, Mengcheng, et al.
Publicado: (2020)

Clinicopathological characteristics and postoperative prognosis of patients with nuclear pedigree of esophageal squamous cell carcinoma
por: Wei, Meng Xia, et al.
Publicado: (2023)

Clinical relevance of tertiary lymphoid structures in esophageal squamous cell carcinoma
por: Deguchi, Sota, et al.
Publicado: (2022)

Cancer stem cells in esophageal squamous cell cancer
por: Wu, Qian, et al.
Publicado: (2019)

A comparative analysis of clinicopathological factors between esophageal small cell and basaloid squamous cell carcinoma
por: Ishida, Hirotaka, et al.
Publicado: (2019)

Immunotherapy for Esophageal Squamous Cell Carcinoma
por: Kojima, Takashi, et al.
Publicado: (2017)

Differential Expression of Stem Cell Markers in Ocular Surface Squamous Neoplasia
por: Mishra, Dilip Kumar, et al.
Publicado: (2016)

Clinicopathological parameters predicting recurrence of pT1N0 esophageal squamous cell carcinoma
por: Xue, Li-Yan, et al.
Publicado: (2018)

Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma
por: Liu, Wan-li, et al.
Publicado: (2010)

TWIST1 activates cancer stem cell marker genes to promote epithelial-mesenchymal transition and tumorigenesis in esophageal squamous cell carcinoma
por: Khales, Sima Ardalan, et al.
Publicado: (2022)

MAEL as a diagnostic marker for the early detection of esophageal squamous cell carcinoma
por: Abbaszadegan, Mohammad Reza, et al.
Publicado: (2021)

The relevance of RT–PCR markers for metastatic tumour cell detection
por: Chechlińska, M, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_ccibr90t2pumqdlm6sv826l1aa